1 Result(s)

Article

Recent progress of CDK4/6 inhibitors’ current practice in breast cancer

Dysregulated cellular proliferation represents a hallmark feature across all cancers. Aberrant activation of the cyclin-dependent kinase 4 and 6 (CDK4/6) pathway, independent of mitogenic signaling, engenders ...

Xueqing Wang, Shanshan Zhao, Qinghan **n, Yunkun Zhang, Kainan Wang… in Cancer Gene Therapy (2024)